相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Additive effect of prostaglandin E2 and adenosine in mouse experimental autoimmune encephalomyelitis
JingJing Xu et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
New and emerging disease modifying therapies for multiple sclerosis
Shiv Saidha et al.
YEAR IN IMMUNOLOGY (2012)
Immunopathogenesis of multiple sclerosis
Manuel Comabella et al.
CLINICAL IMMUNOLOGY (2012)
Immune Therapy of Multiple Sclerosis - Future Strategies
Sven G. Meuth et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Biologic Therapies: Lessons from Multiple Sclerosis
Subrata Ghosh
DIGESTIVE DISEASES (2012)
被撤回的出版物: Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies (Retracted article. See vol. 17, 2016)
Amedeo Amedei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis
Jeffrey H. Mills et al.
JOURNAL OF IMMUNOLOGY (2012)
Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis
Shu-Qin Yao et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling
Julia M. Martinez Gomez et al.
JOURNAL OF NEUROSCIENCE (2012)
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL
Valerie Rigau et al.
NEUROLOGY (2012)
Current and emerging therapies in multiple sclerosis: a systematic review
Wanda Castro-Borrero et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay
Thomas B. Martins et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
A3 Receptors Are Overexpressed in Pleura from Patients with Mesothelioma and Reduce Cell Growth via Akt/Nuclear Factor-κB Pathway
Katia Varani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The blood-brain barrier, chemokines and multiple sclerosis
David W. Holman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Adenosine receptor targeting in health and disease
Stefania Gessi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
MODULATION OF INNATE IMMUNITY BY ADENOSINE RECEPTOR STIMULATION
Bart P. Ramakers et al.
SHOCK (2011)
Anti-Inflammatory and Immunosuppressive Effects of the A2A Adenosine Receptor
Gillian R. Milne et al.
THESCIENTIFICWORLDJOURNAL (2011)
A(2A) and A(3) adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release
Katia Varani et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes
K. Varani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease
Katia Varani et al.
FASEB JOURNAL (2010)
Normalization of A2A and A3 Adenosine Receptor Up-Regulation in Rheumatoid Arthritis Patients by Treatment With Anti-Tumor Necrosis Factor α but Not Methotrexate
Katia Varani et al.
ARTHRITIS AND RHEUMATISM (2009)
A molecular trio in relapse and remission in multiple sclerosis
Lawrence Steinman
NATURE REVIEWS IMMUNOLOGY (2009)
Suppression of inflammatory and immune responses by the A2A adenosine receptor:: an introduction
T. M. Palmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
NF-kappa B, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
J. Yan et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A2A receptors in inflammation and injury:: lessons learned from transgenic animals
Gyoergy Hasko et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
IL-1β and TNF-α regulation of the adenosine receptor (A2A) expression:: differential requirement for NF-κB binding to the proximal promoter
Silvana Morello et al.
JOURNAL OF IMMUNOLOGY (2006)
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease
K Varani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors
K Varani et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin α4β1
D García-Bernal et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Upregulation of A2A adenosine receptor expression by TNF-α in PBMC of patients with CHF:: A regulatory mechanism of inflammation
PL Capecchi et al.
JOURNAL OF CARDIAC FAILURE (2005)
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis
S Tsutsui et al.
JOURNAL OF NEUROSCIENCE (2004)
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells
S Gessi et al.
CLINICAL CANCER RESEARCH (2004)
Activation of A(2A) adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils
GW Sullivan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Interleukin-1β promotes oligodendrocyte death through glutamate excitotoxicity
JL Takahashi et al.
ANNALS OF NEUROLOGY (2003)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis
JB Johnston et al.
ANNALS OF NEUROLOGY (2001)
分享论文
